Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Biogen Inc Recent news which mentions Biogen Inc < Previous 1 2 3 Next > Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug June 11, 2024 Tags stocks Stock markets Investment Strategy From CNBC.com News Cramer's Lightning Round: Bank of America is a buy May 10, 2024 Tags Business News U/S/ Markets Chevron Corp From CNBC.com News Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up April 24, 2024 Tags Breaking news Business Pharmaceuticals From CNBC.com News 5 things to know before the stock market opens Monday April 22, 2024 Tags International Business Machines Corp JetBlue Airways Corp Mattel Inc From CNBC.com News Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move March 08, 2024 Tags Biotech and Pharmaceuticals Eli Lilly and Co Eisai Co Ltd From CNBC.com News Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start February 20, 2024 Tags Biogen Inc Biotech and Pharmaceuticals Health & Science From CNBC.com News Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies February 13, 2024 Tags Breaking news Pharmaceuticals Business From CNBC.com News 5 things to know before the stock market opens Monday February 12, 2024 Tags Business News Airbnb Inc Biogen Inc From CNBC.com News Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments January 31, 2024 Tags Science Business Pharmaceuticals From CNBC.com News Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma December 20, 2023 Tags Biotech and Pharmaceuticals Pfizer Inc Novo Nordisk A/S From CNBC.com News 5 things to know before the stock market opens Monday November 06, 2023 Tags Under Armour Inc Technology Lucid Group Inc From CNBC.com News More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study October 25, 2023 Tags Biotech and Pharmaceuticals Health care industry Eisai Co Ltd From CNBC.com News Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug August 07, 2023 Tags Health & Science Business News Companies From CNBC.com News Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more July 28, 2023 Tags Chevron Corp Biogen Inc Ford Motor Co From CNBC.com News Stocks making the biggest moves midday: Spotify, RTX, General Electric and more July 25, 2023 Tags Whirlpool Corp Markets Alaska Air Group Inc From CNBC.com News Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch July 25, 2023 Tags Health & Science Biotech and Pharmaceuticals Business News From CNBC.com News 5 things to know before the stock market opens Tuesday July 18, 2023 Tags Meta Platforms Inc Business News Economy From CNBC.com News Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year July 17, 2023 Tags Science Breaking news Business From CNBC.com News Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know July 08, 2023 Tags Politics Biotech and Pharmaceuticals Policy From CNBC.com News Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024 July 07, 2023 Tags Regulations Eisai Co Ltd Health care industry From CNBC.com News Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more July 07, 2023 Tags Meta Platforms Inc Economy Biogen Inc From CNBC.com News Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more July 07, 2023 Tags Business Bloom Energy Corp Levi Strauss & Co From CNBC.com News Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug July 07, 2023 Tags Biotech and Pharmaceuticals Social issues Biogen Inc From CNBC.com News FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage July 06, 2023 Tags Business World News Science From CNBC.com News Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more June 13, 2023 Tags Morgan Stanley Norwegian Cruise Line Holdings Ltd Royal Caribbean Cruises Ltd From CNBC.com News FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval June 09, 2023 Tags Business World News Science From CNBC.com News Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action June 07, 2023 Tags Business Alzheimer's disease Breaking News: Business From CNBC.com News Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on May 15, 2023 Tags Markets Stock Picks Investment strategy From CNBC.com News Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates May 12, 2023 Tags Policy U/S/ Economy Eli Lilly and Co From CNBC.com News Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more May 03, 2023 Tags Paycom Software Inc Starbucks Corp Markets From CNBC.com News < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.